Timber Creek Capital Management LLC Buys 2,064 Shares of Elevance Health, Inc. $ELV

Timber Creek Capital Management LLC grew its stake in shares of Elevance Health, Inc. (NYSE:ELV) by 12.4% in the fourth quarter, according to the company in its most recent filing with the SEC. The firm owned 18,716 shares of the company’s stock after acquiring an additional 2,064 shares during the quarter. Elevance Health comprises about 1.5% of Timber Creek Capital Management LLC’s portfolio, making the stock its 23rd biggest holding. Timber Creek Capital Management LLC’s holdings in Elevance Health were worth $6,561,000 as of its most recent filing with the SEC.

Several other large investors also recently modified their holdings of the stock. Murphy Middleton Hinkle & Parker Inc. acquired a new stake in shares of Elevance Health during the 4th quarter worth approximately $5,941,000. Evergreen Wealth Management LLC raised its position in Elevance Health by 33.5% during the third quarter. Evergreen Wealth Management LLC now owns 17,283 shares of the company’s stock valued at $5,584,000 after purchasing an additional 4,336 shares in the last quarter. Blume Capital Management Inc. raised its position in Elevance Health by 236.7% during the third quarter. Blume Capital Management Inc. now owns 6,145 shares of the company’s stock valued at $1,986,000 after purchasing an additional 4,320 shares in the last quarter. Canoe Financial LP lifted its stake in Elevance Health by 18.1% during the third quarter. Canoe Financial LP now owns 389,399 shares of the company’s stock worth $125,823,000 after purchasing an additional 59,743 shares during the last quarter. Finally, Victory Capital Management Inc. boosted its holdings in shares of Elevance Health by 31.1% in the 3rd quarter. Victory Capital Management Inc. now owns 461,693 shares of the company’s stock valued at $149,182,000 after purchasing an additional 109,462 shares in the last quarter. 89.24% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several brokerages have recently issued reports on ELV. Wells Fargo & Company decreased their price target on Elevance Health from $424.00 to $391.00 and set an “overweight” rating on the stock in a research note on Friday, January 30th. Leerink Partners raised their price objective on Elevance Health from $350.00 to $357.00 and gave the company a “market perform” rating in a research note on Thursday, January 29th. Wolfe Research set a $425.00 target price on Elevance Health and gave the company an “outperform” rating in a research report on Thursday, January 8th. Wall Street Zen downgraded Elevance Health from a “buy” rating to a “hold” rating in a research note on Sunday, February 8th. Finally, Barclays dropped their target price on shares of Elevance Health from $404.00 to $393.00 and set an “overweight” rating for the company in a report on Friday, January 30th. Twelve investment analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, Elevance Health has an average rating of “Hold” and an average price target of $384.67.

Elevance Health Stock Up 1.5%

Shares of ELV opened at $316.07 on Tuesday. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.54 and a current ratio of 1.54. Elevance Health, Inc. has a 52 week low of $273.71 and a 52 week high of $443.29. The stock has a market capitalization of $69.43 billion, a price-to-earnings ratio of 12.58, a PEG ratio of 1.71 and a beta of 0.49. The stock has a fifty day moving average of $310.73 and a 200-day moving average of $332.12.

Elevance Health (NYSE:ELV) last issued its quarterly earnings data on Wednesday, January 28th. The company reported $3.33 earnings per share for the quarter, topping analysts’ consensus estimates of $3.10 by $0.23. Elevance Health had a return on equity of 15.59% and a net margin of 2.84%.The business had revenue of $49.31 billion for the quarter, compared to analyst estimates of $49.52 billion. During the same quarter in the previous year, the company posted $3.84 EPS. Elevance Health’s quarterly revenue was up 9.6% compared to the same quarter last year. Elevance Health has set its FY 2026 guidance at 25.500- EPS. As a group, sell-side analysts anticipate that Elevance Health, Inc. will post 33.96 earnings per share for the current fiscal year.

Elevance Health Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, March 25th. Stockholders of record on Tuesday, March 10th were issued a dividend of $1.72 per share. This represents a $6.88 annualized dividend and a dividend yield of 2.2%. This is an increase from Elevance Health’s previous quarterly dividend of $1.71. The ex-dividend date was Tuesday, March 10th. Elevance Health’s dividend payout ratio (DPR) is presently 27.39%.

Elevance Health Company Profile

Elevance Health, Inc (NYSE: ELV) is a large U.S.-based health benefits company that provides a broad range of health insurance products and related services. Headquartered in Indianapolis, the company rebranded from Anthem, Inc to Elevance Health in 2022 while continuing to operate consumer-facing health plans under established state and national brands. Gail Boudreaux serves as chief executive officer and president, leading the company’s strategic focus on integrated health care and benefit delivery.

Elevance’s core activities include offering medical and specialty health plans for individuals, employers and government programs, including Medicare and Medicaid managed-care products.